Lapatinib or trastuzumab in combination with an aromatase inhibitor for first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2

被引：5

作者：

Doss, Sally ^{[1
]}

Robertson, Janet ^{[1
]}

Adam, Jane ^{[1
]}

机构：

[1] Natl Inst Hlth & Clin Excellence, London, England

来源：

LANCET ONCOLOGY | 2012年 / 13卷 / 08期

关键词：

D O I：

10.1016/S1470-2045(12)70290-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：766 / 767

页数：2

共 7 条

[1]

Fleeman N, 2010, LAPATINIB TRASTUZUMA

[2]

Huober J, 2009, CANCER RES, V69, P4094, DOI DOI 10.1158/0008-5472.SABCS-09-4094

[3]

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast Cancer [J].

Johnston, Stephen ;

Pippen, John, Jr. ;

Pivot, Xavier ;

Lichinitser, Mikhail ;

Sadeghi, Saeed ;

Dieras, Veronique ;

Gomez, Henry Leonidas ;

Romieu, Gilles ;

Manikhas, Alexey ;

Kennedy, M. John ;

Press, Michael F. ;

Maltzman, Julie ;

Florance, Allison ;

O'Rourke, Lisa ;

Oliva, Cristina ;

Stein, Steven ;

Pegram, Mark .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) :5538-5546

[4]

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study [J].

Kaufman, Bella ;

Mackey, John R. ;

Clemens, Michael R. ;

Bapsy, Poonamalle P. ;

Vaid, Ashok ;

Wardley, Andrew ;

Tjulandin, Sergei ;

Jahn, Michaela ;

Lehle, Michaela ;

Feyereislova, Andrea ;

Revil, Cedric ;

Jones, Alison .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) :5529-5537

[5]

National Institute for Health and Care Excellence (NICE), 2009, Appraising life-extending, end of life treatments

[6]

NICE, 2012, TECHN APPR GUID TA25

[7]

NICE, 2011, FIN APPR DET LAP TRA

← 1 →